发明名称 DIETHYL-[6-(4-HYDROXYCARBAMOYL-PHENYL-CARBAMOYLOXY-METHYL)-NAPHTHALEN-2-YL-METHYL]-AMMONIUM CHLORIDE FOR USE IN THE TREATMENT OF MUSCULAR DYSTROPHY
摘要 The present invention relates to a method for treating muscular dystrophy which comprises administering diethyl-[6-(4-hydroxycarbamoyl-phenyl-carbamoyloxy-methyl)-naphthalen-2-yl-methyl]-ammonium chloride or other pharmaceutically acceptable salts and/or solvates thereof to a patient in need of such a treatment.;The invention further relates to a method for treating muscular dystrophy which comprises administering diethyl-[6-(4-hydroxycarbamoyl-phenyl-carbamoyloxy-methyl)-naphthalen-2-yl-methyl]-ammonium chloride or other pharmaceutically acceptable salts and/or solvates thereof in combination with one or more additional anti-inflammatory active agents to a patient in need of such a treatment.
申请公布号 US2014370089(A1) 申请公布日期 2014.12.18
申请号 US201414444959 申请日期 2014.07.28
申请人 ITALFARMACO S.P.A. 发明人 Saccone Valentina;Consalvi Silvia;Puri Pier Lorenzo;Mascagni Paolo
分类号 A61K31/325;A61K45/06 主分类号 A61K31/325
代理机构 代理人
主权项 1. A method for treating muscular dystrophy in a patient, comprising administering to a patient in need thereof diethyl-[6-(4-hydroxycarbamoyl-phenylcarbamoyloxymethyl)-naphthalen-2-yl-methyl]-ammonium chloride, or the pharmaceutically acceptable salts and/or solvates thereof.
地址 Milan IT